ArticleWorld journal of surgical oncology2025
Contribution of surgical oncology to the surgical volume of tertiary hospitals in Benin.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer burden is rising in sub-Saharan Africa, where late presentation is common. Surgical oncology is pivotal for diagnosis, curative-intent management, and palliation, yet its contribution to hospital surgical activity in Benin remains undocumented.
objectiveThis study aimed to assess the contribution of surgical oncology to the overall surgical workload in tertiary hospitals in the Littoral Department of Benin and to describe the epidemiological profile, case distribution, and early outcomes of operated patients.
methodsWe conducted a retrospective, hospital-based cross-sectional study across three tertiary referral hospitals. Retrospective data were extracted from operative logs, anesthesia records, and surgical ward files for all surgical procedures performed from January 1 to December 31, 2023.Cancer-related operations were identified and analyzed. Descriptive statistics were used to summarize the characteristics of the patients and surgeries performed. Additionally, 30-day postoperative survival was estimated using Kaplan–Meier methods.
resultsOf the 7,902 surgical procedures performed in 2023, 155 were cancer-related, accounting for 1.96% of the overall surgical volume. The most common cancer sites were breast (n = 36; 23.2%), prostate (n = 24; 15.5%), stomach (n = 16; 10.3%), colon (n = 16; 10.3%), and rectum (n = 10; 6.5%). Most patients presented with advanced disease, with 53.5% diagnosed at stage III–IV (stage III: n = 47; 30.3%; stage IV: n = 36; 23.2%). Open surgery was the predominant surgical approach (n = 125; 80.6%). Postoperative complications occurred in 23 patients (19.7% of the 117 patients with available data). Among the 114 patients with follow-up data suitable for survival analysis, seven patients had died, corresponding to a crude postoperative mortality rate of 6.1% (n = 7). At 30 days postoperatively, the estimated 30-day survival probability was 94% (95% CI: 89–99%).
conclusionIn 2023, oncologic surgeries represented a small fraction of surgical operations performed in the three tertiary hospitals located in the Littoral Department of Benin. Most surgical cases corresponded to advanced-stage tumors, reflecting the severity of disease among patients reaching surgical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.